PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 3, 2026Precision and Future Medicine0 citationsOpen Access

Ocular and optic nerve complications following SARS-CoV-2 infection and vaccination

MVMc Neil ValenciaMAMuhammad hedir AliSLSeung Hwan Lee

Key Points

  • This review aims to summarize ocular and optic nerve complications linked to SARS-CoV-2 infection and vaccination.
  • Reviewed studies published between 2019 and June 2025
  • Selected based on clinical relevance
  • Analyzed ocular manifestations and proposed mechanisms
  • Reported increases in ocular adverse events following COVID-19 infection and vaccination
  • Identified common conditions like uveitis and optic neuritis
  • Highlighted rarer conditions such as acute macular neuroretinopathy

Abstract

The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), primarily affects the respiratory system but can also involve multiple organs, including the often-overlooked ocular system. An increasing number of population-based and retrospective case series studies have reported that ocular and neuro-ophthalmic complications are temporally associated with COVID-19 infection and vaccination. Furthermore, some data suggest a modest increase in ocular adverse events (OAEs) following infection or vaccination, particularly among individuals with autoimmune or pre-existing ocular conditions. The proposed immune-mediated mechanisms include immune responses following vaccination that may contribute to demyelination through molecular mimicry, a phenomenon in which antigens share structural or functional similarities with host self-antigens. In this review, we summarize studies published between 2019 and June 2025, retrieved from PubMed and Google Scholar databases. Studies were selected based on their clinical relevance and contribution to the understanding of OAEs in the context of SARS-CoV-2 infection and COVID-19 vaccination. Thematic tables highlight the clinical spectrum of reported ocular manifestations, ranging from common conditions such as uveitis, optic neuritis, retinal vascular occlusions, and cranial nerve palsies to rarer entities, including acute macular neuroretinopathy, thyroid eye disease, and papillophlebitis. This review presents recent evidence on the proposed pathophysiological mechanisms and risk profiles of COVID-19-related OAEs, with the aim of improving awareness, promoting timely ophthalmic evaluation, and supporting surveillance and future research to clarify causality and inform preventive strategies.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Valencia et al. (2026) studied this question.

synapsesocial.com/papers/69cf5de95a333a821460bf39https://doi.org/10.23838/pfm.2025.00345
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Ophthalmic complications associated with COVID-19: a large US national database analysis2025 · 3 citations
  2. 2Connecting the Dots Between the Eyes, the Brain, and COVID-192025
  3. 3COVID-19: ocular manifestations and associations with corneal transplant rejection and uveitis reactivation2025
  4. 4The Review of Ophthalmic Symptoms in COVID-192024 · 3 citations
  5. 5Incidence and Clinical Characteristics of COVID-19 Ophthalmopathy Following the Termination of Dynamic Zero COVID-19 Strategy in China2024 · 1 citations